scholarly journals Photon-counting cine-cardiac CT in the mouse

2019 ◽  
Author(s):  
Darin P. Clark ◽  
Matthew Holbrook ◽  
Chang-Lung Lee ◽  
Cristian T. Badea

AbstractThe maturation of photon-counting detector (PCD) technology promises to enhance routine CT imaging applications with high-fidelity spectral information. In this paper, we demonstrate the power of this synergy and our complementary reconstruction techniques, performing 4D, cardiac PCD-CT data acquisition and reconstruction in a mouse model of atherosclerosis, including calcified plaque. Specifically,in vivocardiac micro-CT scans were performed in four ApoE knockout mice, following their development of calcified plaques. The scans were performed with a prototype PCD (DECTRIS, Ltd.) with 4 energy thresholds. Projection sampling was performed with 10 ms temporal resolution, allowing the reconstruction of 10 cardiac phases at each of 4 energies (40, 3D volumes per mouse scan). Reconstruction was performed iteratively using the split Bregman method with constraints on spectral rank and spatio-temporal gradient sparsity. The reconstructed images represent the firstin vivo, 4D PCD-CT data in a mouse model of atherosclerosis. Robust regularization during iterative reconstruction yields high-fidelity results: an 8-fold reduction in noise standard deviation for the highest energy threshold (relative to algebraic reconstruction), while absolute spectral bias measurements remain below 13 Hounsfield units across all energy thresholds and scans. Qualitatively, image domain material decomposition results show clear separation of iodinated contrast and soft tissue from calcified plaque in thein vivodata. Quantitatively, spatial, spectral, and temporal fidelity are verified through a water phantom scan and a realistic MOBY phantom simulation experiment: spatial resolution is robustly preserved by iterative reconstruction (10% MTF: 2.8-3.0 lp/mm), left-ventricle, cardiac functional metrics can be measured from iodine map segmentations with ∼1% error, and small calcifications (615 μm) can be detected during slow moving phases of the cardiac cycle. Given these preliminary results, we believe that PCD technology will enhance dynamic CT imaging applications with high-fidelity spectral and material information.

Author(s):  
Yidi Yao ◽  
Liang Li ◽  
Zhiqiang Chen

Abstract Multi-energy spectral CT has a broader range of applications with the recent development of photon-counting detectors. However, the photons counted in each energy bin decrease when the number of energy bins increases, which causes a higher statistical noise level of the CT image. In this work, we propose a novel iterative dynamic dual-energy CT algorithm to reduce the statistical noise. In the proposed algorithm, the multi-energy projections are estimated from the dynamic dual-energy CT data during the iterative process. The proposed algorithm is verified on sufficient numerical simulations and a laboratory two-energy-threshold PCD system. By applying the same reconstruction algorithm, the dynamic dual-energy CT's final reconstruction results have a much lower statistical noise level than the conventional multi-energy CT. Moreover, based on the analysis of the simulation results, we explain why the dynamic dual-energy CT has a lower statistical noise level than the conventional multi-energy CT. The reason is that: the statistical noise level of multi-energy projection estimated with the proposed algorithm is much lower than that of the conventional multi-energy CT, which leads to less statistical noise of the dynamic dual-energy CT imaging.


2012 ◽  
Vol 39 (9) ◽  
pp. 5697-5707 ◽  
Author(s):  
Christian Thibaudeau ◽  
Philippe Bérard ◽  
Marc-André Tétrault ◽  
Jean-Daniel Leroux ◽  
Mélanie Bergeron ◽  
...  

Pharmaceutics ◽  
2022 ◽  
Vol 14 (1) ◽  
pp. 121
Author(s):  
Romain Giraud ◽  
Anaïs Moyon ◽  
Stéphanie Simoncini ◽  
Anne-Claire Duchez ◽  
Vincent Nail ◽  
...  

Microvesicles, so-called endothelial large extracellular vesicles (LEVs), are of great interest as biological markers and cell-free biotherapies in cardiovascular and oncologic diseases. However, their therapeutic perspectives remain limited due to the lack of reliable data regarding their systemic biodistribution after intravenous administration. Methods: Applied to a mouse model of peripheral ischemia, radiolabeled endothelial LEVs were tracked and their in vivo whole-body distribution was quantified by microSPECT/CT imaging. Hindlimb perfusion was followed by LASER Doppler and motility impairment function was evaluated up to day 28 post-ischemia. Results: Early and specific homing of LEVs to ischemic hind limbs was quantified on the day of ischemia and positively correlated with reperfusion intensity at a later stage on day 28 after ischemia, associated with an improved motility function. Conclusions: This concept is a major asset for investigating the biodistribution of LEVs issued from other cell types, including cancer, thus partly contributing to better knowledge and understanding of their fate after injection.


Molecules ◽  
2021 ◽  
Vol 26 (23) ◽  
pp. 7360
Author(s):  
Anthony-David T. Campoy ◽  
Christopher Liang ◽  
Reisha M. Ladwa ◽  
Krystal K. Patel ◽  
Ishani H. Patel ◽  
...  

We report [18F]nifene binding to α4β2* nicotinic acetylcholinergic receptors (nAChRs) in Parkinson’s disease (PD). The study used transgenic Hualpha-Syn(A53T) PD mouse model of α-synucleinopathy for PET/CT studies in vivo and autoradiography in vitro. Additionally, postmortem human PD brain sections comprising of anterior cingulate were used in vitro to assess translation to human studies. Because the small size of mice brain poses challenges for PET imaging, improved methods for radiosynthesis of [18F]nifene and simplified PET/CT procedures in mice were developed by comparing intravenous (IV) and intraperitoneal (IP) administered [18F]nifene. An optimal PET/CT imaging time of 30–60 min post injection of [18F]nifene was established to provide thalamus to cerebellum ratio of 2.5 (with IV) and 2 (with IP). Transgenic Hualpha-Syn(A53T) mice brain slices exhibited 20–35% decrease while in vivo a 20–30% decrease of [18F]nifene was observed. Lewy bodies and α-synuclein aggregates were confirmed in human PD brain sections which lowered the [18F]nifene binding by more than 50% in anterior cingulate. Thus [18F]nifene offers a valuable tool for PET imaging studies of PD.


2021 ◽  
Vol 9 (6) ◽  
pp. 504-504
Author(s):  
Lianggeng Gong ◽  
Yingying Weng ◽  
Wei Zhou ◽  
Kunchi Zhang ◽  
Wei Li ◽  
...  

2015 ◽  
Vol 63 (S 01) ◽  
Author(s):  
C. Heim ◽  
S. Müller ◽  
B. Weigmann ◽  
M. Ramsperger-Gleixner ◽  
N. Koch ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document